Information:
Fel:
Nyckelord
Diffuse Small Cleaved-Cell Lymphoma ×
- Clinical Trial (240)
- Hematology (105)
- Eligibility Determination (104)
- Laboratories (21)
- Medical Oncology (21)
- On-Study Form (17)
- Disease Response (16)
- Treatment Form (13)
- Lymphoma, B-Cell (10)
- Follow-Up Studies (10)
- Lymphoma (9)
- Physical Examination (8)
- Registration (7)
- Off-Treatment (7)
- HIV (7)
- Lymphoma, Large B-Cell, Diffuse (6)
- Lymphoma, AIDS-Related (5)
- Baseline (5)
- Chemotherapy, Adjuvant (4)
- Adverse event (4)
- Death (4)
- Pathology (4)
- Survival (3)
- Radioimmunotherapy (3)
- Toxicity Tests (3)
- Positron-Emission Tomography (3)
- Demography (3)
- Hodgkin Disease (3)
- Infusions, Intravenous (3)
- Radiology (2)
- Biopsy (2)
- Clinical Chemistry Tests (2)
- Consensus (2)
- Concomitant Medication (2)
- Disease Status (2)
- Drug Therapy (2)
- Infection (2)
- Iodine (2)
- Medical History Taking (2)
- Antibodies (2)
- Neoplasms (2)
- Quality of Life (1)
- Questionnaires (1)
- Radiation Dosage (1)
- Whole-Body Irradiation (1)
- Gamma Cameras (1)
- Helicobacter pylori (1)
- Clinical Trial, Phase I (1)
- Lymphoma, B-Cell, Marginal Zone (1)
- Cancer Vaccines (1)
- Lymphoma, Mantle-Cell (1)
- Central Nervous System (1)
- Scores & Instruments (1)
- Classification (1)
- Diagnostic Imaging (1)
- Hematologic Tests (1)
- Lymph Nodes (1)
- Lymphoma, Follicular (1)
- Anti-Infective Agents (1)
- Antibodies, Monoclonal (1)
- Neoplasm Staging (1)
- Patient Admission (1)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
240 Sökresultat.
Item-grupper: Date of physical examination, B- Symptoms, Physical Examination, Organ/ System, Hematology, Chemistry
Item-grupper: Date of physical examination, B- Symptoms, Physical Examination, Organ/ System, Hematology, Chemistry
Item-grupper: Date of physical examination, Visit Week physical examination, B- Symptoms, Physical Examination, Organ/ System, Visit Week laboratory, Hematology, Chemistry
Item-grupper: Biopsy, Biopsy , Lymphoma, Non-Hodgkin | Classification, Pathologist evaluation | Central, Basis of Assessment, Pathologist evaluation | Central | Description, Administrative
Item-grupp: Criteria
Item-grupper: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Intercurrent disease, Footer module
Item-grupper: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Intercurrent disease, Footer module
Item-grupper: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Hematopoietic Regeneration, Intercurrent disease, Footer module
Item-grupper: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Intercurrent disease, Footer module
Item-grupper: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, Intercurrent disease, Footer module
Item-grupper: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Intercurrent disease, Footer module
Item-grupper: PET investigation basic documentation, Extent of examination, Set up equipment, Nodal involvement, Pet result, Footer module